Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Impact of Dietary Intervention on Weight Change in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT01232491

Public ClinicalTrials.gov record NCT01232491. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 8:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 26-week Randomised, Controlled, Open Label, Multicentre, Multinational, Treat to Target Trial Investigating the Impact of Dietary Intervention on Weight Change and the Relationship Between Weight Change and Baseline Body Mass Index (BMI) in Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs) Initiating Insulin Therapy With Insulin Detemir in Combination With Metformin (Levemir DIET)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Europe, and North and South America. The aim of this trial is to investigate if a dietary intervention has an effect on weight when initiating insulin treatment in subjects with type 2 diabetes currently treated with oral antidiabetic drugs (OADs).

Study identification

NCT ID
NCT01232491
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
611 participants

Conditions and interventions

Interventions

Drug · Dietary Supplement

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 29, 2010 (Actual)
Primary completion
Nov 1, 2011 (Actual)
Completion
Nov 14, 2011 (Actual)
Last update posted
May 1, 2017

2010 – 2011

United States locations

U.S. sites
76
U.S. states
30
U.S. cities
66
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35233 —
Novo Nordisk Investigational Site Ozark Alabama 36360 —
Novo Nordisk Investigational Site Anaheim California 92801 —
Novo Nordisk Investigational Site Burlingame California 94010 —
Novo Nordisk Investigational Site Concord California 94520 —
Novo Nordisk Investigational Site Fullerton California 92835 —
Novo Nordisk Investigational Site Long Beach California 90806 —
Novo Nordisk Investigational Site Long Beach California 90807 —
Novo Nordisk Investigational Site Long Beach California 90822 —
Novo Nordisk Investigational Site Montclair California 91763 —
Novo Nordisk Investigational Site National City California 91950 —
Novo Nordisk Investigational Site Redlands California 92374 —
Novo Nordisk Investigational Site Santa Ana California 92705 —
Novo Nordisk Investigational Site Spring Valley California 91978 —
Novo Nordisk Investigational Site Walnut Creek California 94598 —
Novo Nordisk Investigational Site Colorado Springs Colorado 80907 —
Novo Nordisk Investigational Site Norwalk Connecticut 06851 —
Novo Nordisk Investigational Site Bradenton Florida 34201 —
Novo Nordisk Investigational Site Clearwater Florida 33765 —
Novo Nordisk Investigational Site Jacksonville Florida 32204 —
Novo Nordisk Investigational Site Jacksonville Florida 32207 —
Novo Nordisk Investigational Site Jupiter Florida 33458 —
Novo Nordisk Investigational Site Miami Florida 33135 —
Novo Nordisk Investigational Site Pembroke Pines Florida 33027 —
Novo Nordisk Investigational Site Pembroke Pines Florida 33028 —
Novo Nordisk Investigational Site Pembroke Pines Florida 33029 —
Novo Nordisk Investigational Site Atlanta Georgia 30342 —
Novo Nordisk Investigational Site Perry Georgia 31069 —
Novo Nordisk Investigational Site Roswell Georgia 30076 —
Novo Nordisk Investigational Site Oympiafields Illinois 60641 —
Novo Nordisk Investigational Site Evansville Indiana 47714 —
Novo Nordisk Investigational Site Shawnee Mission Kansas 66204 —
Novo Nordisk Investigational Site Topeka Kansas 66606 —
Novo Nordisk Investigational Site Louisville Kentucky 40213 —
Novo Nordisk Investigational Site Portland Maine 04101 —
Novo Nordisk Investigational Site Rockville Maryland 20852 —
Novo Nordisk Investigational Site Brockton Massachusetts 02301 —
Novo Nordisk Investigational Site Buckley Michigan 49620 —
Novo Nordisk Investigational Site Southfield Michigan 48034 —
Novo Nordisk Investigational Site St Louis Missouri 63141 —
Novo Nordisk Investigational Site Berlin New Jersey 08009 —
Novo Nordisk Investigational Site New York New York 10025 —
Novo Nordisk Investigational Site Northport New York 11768 —
Novo Nordisk Investigational Site West Seneca New York 14224 —
Novo Nordisk Investigational Site Charlotte North Carolina 28277 —
Novo Nordisk Investigational Site Durham North Carolina 27710 —
Novo Nordisk Investigational Site Raleigh North Carolina 27609 —
Novo Nordisk Investigational Site Wilmington North Carolina 28401 —
Novo Nordisk Investigational Site Cincinnati Ohio 45245 —
Novo Nordisk Investigational Site Dayton Ohio 45406 —
Novo Nordisk Investigational Site Dayton Ohio 45439 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73103 —
Novo Nordisk Investigational Site Oklahoma City Oklahoma 73104-5020 —
Novo Nordisk Investigational Site Altoona Pennsylvania 16602 —
Novo Nordisk Investigational Site Jenkintown Pennsylvania 19046 —
Novo Nordisk Investigational Site Norristown Pennsylvania 19401 —
Novo Nordisk Investigational Site Anderson South Carolina 29621 —
Novo Nordisk Investigational Site Greer South Carolina 29651 —
Novo Nordisk Investigational Site Rapid City South Dakota 57701 —
Novo Nordisk Investigational Site Bristol Tennessee 37620-7352 —
Novo Nordisk Investigational Site Chattanooga Tennessee 37411 —
Novo Nordisk Investigational Site Kingsport Tennessee 37660 —
Novo Nordisk Investigational Site Nashville Tennessee 37212 —
Novo Nordisk Investigational Site Dallas Texas 75231 —
Novo Nordisk Investigational Site Dallas Texas 75246 —
Novo Nordisk Investigational Site Dallas Texas 75251 —
Novo Nordisk Investigational Site Odessa Texas 79761 —
Novo Nordisk Investigational Site Plano Texas 75075 —
Novo Nordisk Investigational Site St. George Utah 84790 —
Novo Nordisk Investigational Site Norfolk Virginia 23502 —
Novo Nordisk Investigational Site Richmond Virginia 23249 —
Novo Nordisk Investigational Site Richmond Virginia 23294 —
Novo Nordisk Investigational Site Winchester Virginia 22601 —
Novo Nordisk Investigational Site Spokane Washington 99208 —
Novo Nordisk Investigational Site Martinsburg West Virginia 25401 —
Novo Nordisk Investigational Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01232491, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 1, 2017 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01232491 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →